Criminals target sensitive data left unencrypted after digital transformation initiatives
Recursion Pharmceuticals has closed a $121 million Series C funding round, led by Scottish Mortgage Investment Trust, with participation from new and all prior institutional investors. The funds will be invested to continue building Recursion’s AI-enabled drug discovery platform, as well as to develop capabilities to accelerate new chemical entity chemistry and predict safety pharmacology. Recursion […]
ALTEN Calsoft Labs launches blockchain clinical trial platform in partnership with clinical research organisation Clinlogix
The social network for cancer will use the funds to expand its service and enter new markets through its patient engagement platform
Cala Health, which develops bioelectrical therapies for chronic diseases, has closed a $50 million Series C financing round
MedCrypt, a medical device cybersecurity software provider, has closed a Series A round of $5.3 million, led by Section 32, with participation from Eniac Ventures and Y Combinator. The funds will be used for sales and marketing, and for product development.
Ablacon, which is developing an atrial fibrillation (AFib) mapping system, has closed a $21.5 million Series A funding round led by Ajax Health.
908 Devices, a pioneer of analytical devices for chemical and biomolecular analysis, has raised a $17.5 million Series E financing round led by Northpond Ventures.
Redox, which enables healthcare data exchange, has closed a $33 million Series C funding round, led by Battery Ventures.
Sonde Health, which is developing a voice-based diagnostics platform, has secured $16 million in a Series A financing round led by M Ventures, with MP Healthcare Venture Management, Neoteny 4, LP, Canepa Healthcare, and founder PureTech Health